Sangui Biotech International Inc's ability to collect its outstanding accounts receivable from its corporate clients, has improved in the third quarter 2023 to a ratio of 3.38, this is below the company average, and notable indication of worsening business environment. Average receivable collection period, for the Sangui Biotech International Inc in Mar 31 2023 quarter, has decreased to 108 days, compared to 114 days, in the Dec 31 2022 quarter.

If we take a look into Healthcare sector 542 other companies have achieved higher receivables turnover ratio. While total ranking has deteriorated relative to the period ending Mar 31 2023 from 3403 to 3412.

What is Receivable Turnover Ratio?
What is Sangui Biotech International Inc Selling?

What is Receivable Turnover Ratio?

Select the Comparisons :

None ▼

Select the Ratio:

Accounts Receivables Turnover▼

None ▼

Accounts Receivables Turnover▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

SGBI Receivables Turnover Ratio	(Mar 31 2023) III. Quarter	(Dec 31 2022) II. Quarter	(Sep 30 2022) I. Quarter	(Jun 30 2022) IV. Quarter	(Mar 31 2022) III. Quarter
Y / Y Receivable Change	-53.56 %	-35.32 %	1065.14 %	46.79 %	182.23 %
Y / Y Revenue Change	4.14 %	-52.07 %	121.06 %	-24.05 %	-15.24 %
Receivable Turnover Ratio (TTM)	3.38	3.21	3.3	4.9	5.51
SGBI's Total Ranking	# 3412	# 3403	# 1582	# 1585	# 1573
Accounts Receivable average collection period days	108	114	111	74	66
Seq. Receivable Change	-81.88 %	-66.02 %	392.87 %	53.03 %	-74.76 %
Seq. Revenue Change	75.94 %	-74.1 %	290.6 %	-41.49 %	-19.02 %

Receivable Turnover Company Ranking
Within:	No.
Major Pharmaceutical Preparations Industry	# 194
Healthcare Sector	# 543
Overall Market	# 3412

Receivable Turnover Ratio Statistics
High	Average	Low
12.61	4.64	0.63
(Sep 30 2021)		(Sep. 30, 2015)

SGBI Company Profile • Back to SGBI Efficiency Comparisons • Compare SGBI Receivables Turnover Ratio to its Competitors

Financial Statements
Sangui Biotech International Inc's Accounts Receivable	$ 0 Millions	Visit SGBI's Balance sheet
Sangui Biotech International Inc's Sales TTM	$ 0 Millions	Visit SGBI's Income Statement
Sources of SGBI's Revenues		Visit SGBI's Sales by Geography

Other Accounts Receivable Turnover Ratios
Major Pharmaceutical Preparations Industry Accounts Receivable Turnover Trends and Statistics
Healthcare Sector Accounts Receivable Turnover Statistics
Accounts Receivables Turnover Trends for overall market
SGBI's Receivable Turnover Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Accounts Receivables Turnover
Lowest Ranking Accounts Receivables Turnover

You may also want to know
SGBI's Growth Rates	SGBI's Roa	SGBI's Inventory Turnover Ratio	SGBI's Dividend Comparisons
SGBI's Profitability Ratios	SGBI's Roi	SGBI's Asset Turnover Ratio	SGBI's Dividend Growth
SGBI's Valuation Ratios	SGBI's Roe	SGBI's Financial Strength Ratios	SGBI's Dividend Payout Ratio

Companies with similar Receivables Turnover Ratio for the quarter ending Mar 31 2023, within Healthcare Sector	Receivable Turnover Ratio	Revenues for 12 Months ending Mar 31 2023	Receivable at quarter ending Mar 31 2023
Brookdale Senior Living Inc	54.71	$ 2,864.819 Millions	$ 52.368 Millions
Embecta Corp	52.21	$ 1,118.500 Millions	$ 21.425 Millions
Aclaris Therapeutics Inc	51.29	$ 30.827 Millions	$ 0.601 Millions
Reunion Neuroscience Inc	49.77	$ 19.870 Millions	$ 0.399 Millions
Zomedica Corp	47.41	$ 20.661 Millions	$ 0.436 Millions
Sangamo Therapeutics Inc	45.42	$ 241.025 Millions	$ 5.307 Millions
Lifemd Inc	44.92	$ 121.550 Millions	$ 2.706 Millions
Sonida Senior Living Inc	44.88	$ 242.022 Millions	$ 5.392 Millions
Skinvisible Inc	44.86	$ 0.224 Millions	$ 0.005 Millions
Vireo Growth Inc.	43.90	$ 78.076 Millions	$ 1.778 Millions
Wearable Health Solutions, Inc.	43.82	$ 0.834 Millions	$ 0.019 Millions
Fulcrum Therapeutics Inc	43.73	$ 4.045 Millions	$ 0.093 Millions
Ideaya Biosciences Inc	42.98	$ 47.452 Millions	$ 1.104 Millions
Telesis Bio Inc	41.84	$ 122.229 Millions	$ 2.922 Millions
Innoviva Inc	39.37	$ 311.354 Millions	$ 7.909 Millions
Logicmark Inc	39.25	$ 11.076 Millions	$ 0.282 Millions
Alpine Immune Sciences Inc	37.44	$ 25.822 Millions	$ 0.690 Millions
Nature s Sunshine Products inc	37.26	$ 420.050 Millions	$ 11.274 Millions
Streamex Corp	36.52	$ 0.283 Millions	$ 0.008 Millions
Science 37 Holdings Inc	31.84	$ 65.547 Millions	$ 2.059 Millions
Janux Therapeutics Inc	29.03	$ 9.071 Millions	$ 0.313 Millions
National Vision Holdings Inc	28.38	$ 2,040.062 Millions	$ 71.884 Millions
Neptune Wellness Solutions Inc	28.03	$ 52.615 Millions	$ 1.877 Millions
Vivos Therapeutics Inc	26.67	$ 16.237 Millions	$ 0.609 Millions
Inmed Pharmaceuticals Inc	25.88	$ 2.339 Millions	$ 0.090 Millions
Biofrontera Inc	25.82	$ 73.750 Millions	$ 2.857 Millions
Electrocore Inc	24.40	$ 9.473 Millions	$ 0.388 Millions
Kiniksa Pharmaceuticals International Plc	24.21	$ 236.336 Millions	$ 9.763 Millions
Ainos Inc	23.14	$ 3.482 Millions	$ 0.150 Millions
Valion Bio Inc	22.81	$ 1.893 Millions	$ 0.083 Millions

Date modified: 2026-09-18T13:11:05+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.